These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12773205)

  • 61. Selective uptake of cholesteryl ester from low density lipoprotein is involved in HepG2 cell cholesterol homeostasis.
    Charest MC; Rhainds D; Falstrault L; Matzouranis T; Brissette L
    Eur J Biochem; 1999 Jul; 263(2):402-9. PubMed ID: 10406948
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The low-density lipoprotein receptor and cholesterol synthesis are affected differently by dietary cholesterol in the rat.
    Roach PD; Balasubramaniam S; Hirata F; Abbey M; Szanto A; Simons LA; Nestel PJ
    Biochim Biophys Acta; 1993 Oct; 1170(2):165-72. PubMed ID: 8399341
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells.
    Ellsworth JL; Chandrasekaran C; Cooper AD
    Biochem J; 1991 Oct; 279 ( Pt 1)(Pt 1):175-87. PubMed ID: 1930137
    [TBL] [Abstract][Full Text] [Related]  

  • 64. LDL receptor gene transcription is selectively induced by t10c12-CLA but not by c9t11-CLA in the human hepatoma cell line HepG2.
    Ringseis R; König B; Leuner B; Schubert S; Nass N; Stangl G; Eder K
    Biochim Biophys Acta; 2006 Oct; 1761(10):1235-43. PubMed ID: 16982210
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hyperexpression of low-density lipoprotein receptors and hydroxy-methylglutaryl-coenzyme A-reductase in human pinguecula and primary pterygium.
    Peiretti E; Dessì S; Putzolu M; Fossarello M
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):3982-5. PubMed ID: 15505045
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Effect of pravastatin on hepatic cholesterol metabolism].
    Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B
    Fortschr Med; 1991 Mar; 109(8):189-94. PubMed ID: 1905265
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, SR-B1, and ACAT in diet-induced syndrome X.
    Roberts CK; Liang K; Barnard RJ; Kim CH; Vaziri ND
    Kidney Int; 2004 Oct; 66(4):1503-11. PubMed ID: 15458444
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by reversible phosphorylation: modulation of enzymatic activity by low density lipoprotein, sterols, and mevalonolactone.
    Beg ZH; Reznikov DC; Avigan J
    Arch Biochem Biophys; 1986 Jan; 244(1):310-22. PubMed ID: 3004340
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Soya phytoestrogens, genistein and daidzein, decrease apolipoprotein B secretion from HepG2 cells through multiple mechanisms.
    Borradaile NM; de Dreu LE; Wilcox LJ; Edwards JY; Huff MW
    Biochem J; 2002 Sep; 366(Pt 2):531-9. PubMed ID: 12030847
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Differential activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase in zones of the adrenal cortex.
    Kubo M; Strott CA
    Endocrinology; 1987 Jan; 120(1):214-21. PubMed ID: 3023027
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevention of cholesteryl ester accumulation in P388D1 macrophage-like cells by increased cellular vitamin E depends on species of extracellular cholesterol. Conventional heterologous non-human cell cultures are poor models of human atherosclerotic foam cell formation.
    Asmis R; Llorente VC; Gey KF
    Eur J Biochem; 1995 Oct; 233(1):171-8. PubMed ID: 7588742
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antioxidative and hypocholesterolemic activities of water-soluble puerarin glycosides in HepG2 cells and in C57 BL/6J mice.
    Chung MJ; Sung NJ; Park CS; Kweon DK; Mantovani A; Moon TW; Lee SJ; Park KH
    Eur J Pharmacol; 2008 Jan; 578(2-3):159-70. PubMed ID: 17976573
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relationship of genetic variation in genes encoding apolipoprotein A-IV, scavenger receptor BI, HMG-CoA reductase, CETP and apolipoprotein E with cholesterol metabolism and the response to plant stanol ester consumption.
    Plat J; Mensink RP
    Eur J Clin Invest; 2002 Apr; 32(4):242-50. PubMed ID: 11952809
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 3-Hydroxy-3-methylglutaryl coenzyme A reductase in anencephalic and normal human fetal liver.
    Carr BR; Rainey WE; Mason JI
    J Clin Invest; 1985 Nov; 76(5):1946-9. PubMed ID: 2997298
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase unmask transcriptional regulation of hepatic low-density lipoprotein receptor gene expression by dietary cholesterol.
    Lopez D; Ness GC
    Arch Biochem Biophys; 1997 Aug; 344(1):215-9. PubMed ID: 9244400
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacometabolomics for the Study of Lipid-Lowering Therapies: Opportunities and Challenges.
    Gianazza E; Brioschi M; Iezzi A; Paglia G; Banfi C
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834701
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antioxidant Supplements Improve Profiles of Hepatic Oxysterols and Plasma Lipids in Butter-fed Hamsters.
    Poirier J; Cockell KA; Ratnayake WM; Scoggan KA; Hidiroglou N; Gagnon C; Rocheleau H; Gruber H; Griffin P; Madère R; Trick K; Kubow S
    Nutr Metab Insights; 2010; 3():1-14. PubMed ID: 23966787
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment.
    Trupp M; Zhu H; Wikoff WR; Baillie RA; Zeng ZB; Karp PD; Fiehn O; Krauss RM; Kaddurah-Daouk R
    PLoS One; 2012; 7(7):e38386. PubMed ID: 22808006
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anti-atherosclerotic effects of vitamin E--myth or reality?
    Munteanu A; Zingg JM; Azzi A
    J Cell Mol Med; 2004; 8(1):59-76. PubMed ID: 15090261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.